
KPV
KPV (Lys-Pro-Val), C-terminal tripeptide of alpha-MSH
Single peptideSource verified
- Evidence
- Animal research
- Route
- Oral and intraperitoneal in mouse models, including a nanoparticle-delivered oral formulation. No human route has been studied.
- Schedule
- Not established. No human schedule exists, and animal experiments used study-specific regimens.
- Vials
- 5 mg, 10 mg
View protocol6 citations
